Well now, how can biosigs drug not meet it's endpoint when it's using the amazing already approved drug of remdesivir right along with its own drug. That alone should catapult it to the next level of phase 3. I know, perhaps biosigs drug is suppressing the valiant effort of remdesivir to save these patients. Must be the reason because why would a drug be approved for an indication that it didn't actually work for? (No sarcasm was harmed in the penning of this post)